CALCEMIN SILVER- calcium carbonate tablet, film coated

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

BORON (UNII: N9E3X5056Q) (BORON - UNII:N9E3X5056Q), MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838), ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)

Available from:

Bayer HealthCare LLC.

INN (International Name):

BORON

Composition:

BORON 2.6 mg

Administration route:

ORAL

Prescription type:

OTC DRUG

Authorization status:

Export only

Summary of Product characteristics

                                CALCEMIN SILVER- CALCIUM CARBONATE TABLET, FILM COATED
BAYER HEALTHCARE LLC.
----------
CALCEMIN SILVER
DRUG FACTS
_DRUG FACTS_
CALCEMIN SILVER
calcium carbonate tablet, film coated
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:0 28 0 -0 273
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
BO RO N (UNII: N9 E3X50 56 Q) (BORON - UNII:N9 E3X50 56 Q)
BORON
2.6 mg
MAGNESIUM O XIDE (UNII: 3A3U0 GI71G) (MAGNESIUM CATION - UNII:T6
V3LHY8 38 )
MAGNESIUM OXIDE
40 mg
ZINC O XIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)
ZINC OXIDE
7.5 mg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SO DIUM LAURYL SULFATE (UNII: 36 8 GB5141J)
MAGNESIUM STEARATE (UNII: 70 0 9 7M6 I30 )
TITANIUM DIO XIDE (UNII: 15FIX9 V2JP)
HYPRO MELLO SES (UNII: 3NXW29 V3WO)
TRIACETIN (UNII: XHX3C3X6 73)
MINERAL O IL (UNII: T5L8 T28 FGP)
FD&C BLUE NO . 2 (UNII: L0 6 K8 R7DQK)
FD&C YELLO W NO . 6 (UNII: H77VEI9 3A8 )
CRO SCARMELLO SE (UNII: 0 29 TFK9 9 2N)
CELLULO SE, MICRO CRYSTALLINE (UNII: OP1R32D6 1U)
MAGNESIUM SILICATE (UNII: 9 B9 6 9 1B2N9 )
WATER (UNII: 0 59 QF0 KO0 R)
STEARIC ACID (UNII: 4ELV7Z6 5AP)
PRODUCT CHARACTERISTICS
COLOR
white (Silver)
S CORE
no sco re
S HAP E
OVAL
S IZ E
15mm
FLAVOR
IMPRINT CODE
No ne
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:0 28 0 -0 273-30
1 in 1 CARTON
0 4/0 1/20 16
1
30 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct
2
NDC:0 28 0 -0 273-6 0
1 in 1 CARTON
0 4/0 1/20 16
2
6 0 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct
Bayer HealthCare LLC.
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
Expo rt o nly
0 4/0 1/20 16
LABELER -
Bayer HealthCare LLC. (112117283)
Revised: 1/2021
                                
                                Read the complete document